Fushine Pharmaceutical (300497.SZ) announced that its affiliated company, Shanghai Lingkai Technology Co., Ltd. (referred to as "Lingkai Technology"), intends to apply for the first public offering of overseas-listed shares (H shares) and be listed on the main board of the Hong Kong Exchange for strategic development.
富祥药业(300497.SZ)：凌凯科技拟申请境外上市
Jiangxi Fushine Pharmaceutical (300497.SZ): Lingkai Technology plans to apply for overseas listing.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.